Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine

(1) Background: Heart failure with reduced ejection fraction (HFrEF) remains a major health burden. Angiotensin-Receptor-Neprilysin-Inhibitors (ARNIs) are an established HFrEF therapy which increases natriuretic peptide levels by inhibiting neprilysin. Leptin is a lipid metabolism parameter, which i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnewein, Bernhard, Shomanova, Zornitsa, Paar, Vera, Topf, Albert, Jirak, Peter, Fiedler, Lukas, Granitz, Christina, Van Almsick, Vincent, Semo, Dilvin, Zagidullin, Naufal, Dieplinger, Anna-Maria, Sindermann, Juergen, Reinecke, Holger, Hoppe, Uta C., Pistulli, Rudin, Motloch, Lukas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179018/
https://www.ncbi.nlm.nih.gov/pubmed/37176525
http://dx.doi.org/10.3390/jcm12093083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179018/
https://www.ncbi.nlm.nih.gov/pubmed/37176525
http://dx.doi.org/10.3390/jcm12093083

Ejemplares similares